Search research articles
Contact Us
Filters
Showing results (521-530 of 651) with videos related to
Page
of 66
Sort By:
Neurology
|
August 26, 1998
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group
G D Borasio, W Robberecht, P N Leigh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 21, 2017
Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis
Wendeline Reniers, Maarten Schrooten, Kristl G Claeys, et al.
Journal of Alzheimer'S Disease : JAD
|
July 10, 2016
The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease
Ann De Vos, Hanne Struyfs, Dirk Jacobs, et al.
British Journal of Pharmacology
|
October 13, 2000
Evidence for VIP(1)/PACAP receptors in the afferent pathway mediating surgery-induced fundic relaxation in the rat
G E Boeckxstaens, M Hollmann, S H Heisterkamp, et al.
Plos One
|
April 6, 2013
CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression
Valerie Pede, Ans Rombout, Jolien Vermeire, et al.
Journal of Neurochemistry
|
December 24, 2009
Pathogenic cysteine mutations affect progranulin function and production of mature granulins
Jun Wang, Philip Van Damme, Carlos Cruchaga, et al.
European Journal of Biochemistry
|
June 27, 2002
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates VIP/PACAP receptor activity
Salvatore De Maria, Salvatore Metafora, Vittoria Metafora, et al.
Neuromuscular Disorders : NMD
|
January 27, 2009
Peripheral neuropathy and 46XY gonadal dysgenesis: a heterogeneous entity
Jonathan Baets, Ines Dierick, Chantal Ceuterick-de Groote, et al.
Nature Medicine
|
July 26, 2011
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease
Constantin d'Ydewalle, Jyothsna Krishnan, Driss M Chiheb, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 13, 2016
ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis
Dominique Turck, Christian P Braegger, Carla Colombo, et al.
Page
of 66
Search research articles
Search
Showing results (521-530 of 651) with videos related to
Sort By:
Page
of 66
Neurology
|
August 26, 1998
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group
G D Borasio, W Robberecht, P N Leigh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 21, 2017
Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis
Wendeline Reniers, Maarten Schrooten, Kristl G Claeys, et al.
Journal of Alzheimer'S Disease : JAD
|
July 10, 2016
The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease
Ann De Vos, Hanne Struyfs, Dirk Jacobs, et al.
British Journal of Pharmacology
|
October 13, 2000
Evidence for VIP(1)/PACAP receptors in the afferent pathway mediating surgery-induced fundic relaxation in the rat
G E Boeckxstaens, M Hollmann, S H Heisterkamp, et al.
Plos One
|
April 6, 2013
CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression
Valerie Pede, Ans Rombout, Jolien Vermeire, et al.
Journal of Neurochemistry
|
December 24, 2009
Pathogenic cysteine mutations affect progranulin function and production of mature granulins
Jun Wang, Philip Van Damme, Carlos Cruchaga, et al.
European Journal of Biochemistry
|
June 27, 2002
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates VIP/PACAP receptor activity
Salvatore De Maria, Salvatore Metafora, Vittoria Metafora, et al.
Neuromuscular Disorders : NMD
|
January 27, 2009
Peripheral neuropathy and 46XY gonadal dysgenesis: a heterogeneous entity
Jonathan Baets, Ines Dierick, Chantal Ceuterick-de Groote, et al.
Nature Medicine
|
July 26, 2011
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease
Constantin d'Ydewalle, Jyothsna Krishnan, Driss M Chiheb, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 13, 2016
ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis
Dominique Turck, Christian P Braegger, Carla Colombo, et al.
Page
of 66